Anavex Life Sciences Corp (AVXL)

[Talon38]

George. CTAD..There are some key take aways looking thru the CTAD presentations and posters.

1. Two of our SAB members, Paul Aisen and Jeffery Cummings, play significant roles as moderators and presenters.......but not for Anavex.

2. The discussion of amyloid and tau as key elements in Alzheimer's is still very much alive.

3. A number of drugs with discontinued trials (failed) are still being kept alive by their Pharmas:

Biogen's Aducanumab ( 1 hour leadoff presentation on Thursday...no others at 1 hour long)
Eisai/Biogen's BAN2401
Merck's Verabecestat
Roche's Crenezumab and Gantenerumab

4. There are even a couple of P1 trial presentations and a lot of academic research into various dementia related subjects.

Will we reach the right ears in our one presentation and three posters this year...we will see.